<code id='D4B109398C'></code><style id='D4B109398C'></style>
    • <acronym id='D4B109398C'></acronym>
      <center id='D4B109398C'><center id='D4B109398C'><tfoot id='D4B109398C'></tfoot></center><abbr id='D4B109398C'><dir id='D4B109398C'><tfoot id='D4B109398C'></tfoot><noframes id='D4B109398C'>

    • <optgroup id='D4B109398C'><strike id='D4B109398C'><sup id='D4B109398C'></sup></strike><code id='D4B109398C'></code></optgroup>
        1. <b id='D4B109398C'><label id='D4B109398C'><select id='D4B109398C'><dt id='D4B109398C'><span id='D4B109398C'></span></dt></select></label></b><u id='D4B109398C'></u>
          <i id='D4B109398C'><strike id='D4B109398C'><tt id='D4B109398C'><pre id='D4B109398C'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:92285

          Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

          advertisement

          For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Readout Newsletter: Bayer study halts, Carmot to IPO, and more
          Readout Newsletter: Bayer study halts, Carmot to IPO, and more

          KenaBetancur/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbi

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc